Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

Share Price is delayed by 15 minutes
Get Live Data
19.45    -0.65 (-3.23%)
Bid:
19.00
Ask:
19.90
Spread: 0.90 (4.737%)
Market Cap: €111.86b
BVA Live PriceLast checked at - London Stock Exchange

Intraday Bbva Ord Share Chart

Share Buyback Program

19 Dec 2025 07:21

RNS Number : 2789M
Banco Bilbao Vizcaya Argentaria SA
19 December 2025
 

Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA" or the "Company"), in compliance with the Spanish Securities Market legislation, hereby proceeds to notify the following:

 

 

INSIDE INFORMATION

 

Further to the notice of inside information of 16 October 2025, with CNMV registration number 2942, BBVA has received the required authorization from the European Central Bank for the buyback and cancellation of own shares of BBVA for a maximum aggregate amount of 3,960 million euros, in one or several tranches and until 8 December 2026 (the "Authorization"). The maximum amount of 3,960 million euros has been fully deducted from BBVA's individual and consolidated common equity tier 1 (CET1) as from the Authorization receipt.

 

Once the Authorization has been obtained, and in exercise of the authority delegated to it by the Annual Shareholders' Meeting of BBVA held on 18 March 2022, the Board of Directors of BBVA, in its meeting held on 18 December 2025, has agreed to carry out a program scheme for the buyback of own shares in accordance with the provisions of Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse and Commission Delegated Regulation (EU) 2016/1052, of 8 March 2016 (together the "Regulations"), which will be executed in several tranches, for a maximum aggregate amount of up to 3,960 million euros, aimed at reducing BBVA's share capital (the "Program Scheme"), notwithstanding the possibility to suspend or early terminate the Program Scheme upon the occurrence of circumstances that make it advisable.

 

Likewise, the Board of Directors has agreed, within the scope of the Program Scheme, to carry out a first tranche in accordance with the provisions of the Regulations with a view to reducing the share capital of BBVA (the "First Tranche") and with the terms and conditions detailed below:

Purpose:

To reduce BBVA's share capital by cancelling the shares acquired.

 

Maximum cash amount:

 

The maximum aggregate cash amount will be 1,500,000,000 euros.

Maximum number of shares:

The maximum number of BBVA shares to be acquired will be 557,316,433.

 

Start of the execution:

Execution will start on 22 December 2025.

End of the execution:

The First Tranche will end neither before 6 March 2026 nor later than 7 April 2026[1] and, in any event, when within such period the maximum cash amount is reached or the maximum number of shares is acquired.

 

However, the Company reserves the right to temporarily suspend execution of the First Tranche or end it early in the event of any circumstance that so advises or requires.

 

Trading Venues:

Purchases shall be made on the Spanish electronic trading system - Continuous Market and on the Cboe Europe, Turquoise Europe and Aquis Exchange trading platforms.

 

Manager:

The First Tranche will be executed externally through J.P. Morgan SE, which will decide independently of the Company on the timing of the purchases of BBVA shares.

 

Minimum Number of Shares Per Day

The Manager shall purchase at least 500,000 BBVA shares on each Trading Day (which is not an Excluded Day nor a Disrupted Day[2]), unless the Manager determines that it would not be possible to achieve the Minimum Number of Shares Per Day without breaching the restrictions and limitations under Delegated Regulation (EU) 2016/1052. Any such occurrence shall be duly disclosed in the periodic communications made in accordance with the Regulations, stating the reason why the Minimum Number of Shares Per Day was not purchased.

 

Other conditions:

The own shares will be purchased observing in all cases the conditions and limits established in the Regulations.

 

The share purchase transactions performed, as well as the end or, as the case may be, the temporary suspension of execution of the First Tranche, will be duly communicated in accordance with the Regulations.

 

 

Madrid, 19 December 2025


[1] However, for each "Excluded Day," the execution period may be postponed by one "Trading Day," up to a maximum postponement until 21 April 2026.

 

A "Trading Day" means each day on which the Continuous Market is scheduled to be open for trading during normal market hours.

 

An "Excluded Day" means any Trading Day on which: (i) any Trading Venue does not open for the entire regular trading session; or (ii) a suspension or limitation on the trading of BBVA shares is imposed on any Trading Venue for the entire regular trading session; or (iii) the trading price of BBVA shares on any Trading Venue is below their nominal value for the entire regular trading session; or (iv) the Company has suspended the execution of the First Tranche.

 

[2] "Disrupted Day" means any Trading Day on which: (i) any Trading Venue is closed for a substantial part of its regular trading session or closes significantly earlier than its scheduled closing time, or there is a significant disruption to trading on any Trading Venue; or (ii) any Trading Venue imposes a suspension or limitation on the trading of BBVA shares for a substantial part of the regular trading session; or (iii) the trading price of BBVA shares on any Trading Venue is below their nominal value for a substantial part of the regular trading session.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUKABRVWUUARA
Date   Source Headline
20th Jan 20215:08 pmRNS4Q20 Results Presentation Announcement
14th Dec 20205:21 pmRNSAgreement with Allianz
27th Nov 20207:00 amRNSEnd of conversations with Banco de Sabadell
16th Nov 20205:13 pmRNSConversations with Banco de Sabadell, S.A.
16th Nov 20207:00 amRNSPresentation_Sale of BBVA's U.S. subsidiary to PNC
16th Nov 20207:00 amRNSSale of BBVA's U.S. subsidiary to PNC
30th Oct 20207:21 amRNS3Q20 Results Presentation
30th Oct 20207:09 amRNS3Q20 Quarterly Report
30th Oct 20207:05 amRNS3Q20 Results Press Release
21st Oct 20205:06 pmRNS3Q20 Results Presentation Announcement
23rd Sep 20207:48 amRNSBBVA CEO Presentation
14th Aug 20209:00 amRNSPost-Stab Notice BBVA GBP 300m
30th Jul 20207:00 amRNS2Q20 Results Presentation
30th Jul 20207:00 amRNS2Q20 Results Report
30th Jul 20207:00 amRNS2Q20 Results Press Release
21st Jul 20204:57 pmRNS2Q20 Results Presentation Announcement
14th Jul 202012:12 pmRNSPre-Stab Notice BBVA GBP 300m due 15th July
7th Jul 20205:20 pmRNSOffer of securities convertible into shares_2
7th Jul 20208:23 amRNSOffer of securities convertible into shares
3rd Jul 202010:34 amRNSPost-stab Notice BBVA EUR 1bn
23rd Jun 20207:00 amRNSFitch Rating Update
27th May 20205:41 pmRNSPre-Stab Notice BBVA EUR 1BN due 4th June 2020
30th Apr 20207:28 amRNS1Q20 Results Press Release
30th Apr 20207:05 amRNSNew Composition BD Committees
30th Apr 20207:05 amRNS1Q20 Results Report
30th Apr 20207:00 amRNS1Q20 Results Presentation
30th Apr 20207:00 amRNSDividend Policy
28th Apr 20207:00 amRNSAgreement between BBVA and Allianz
21st Apr 20205:00 pmRNS1Q20 Results Presentation Announcement
9th Apr 20208:21 amRNSPotential Note Purchase
16th Mar 20207:00 amRNSPrudential Relevance Report (Pillar III) 2019
13th Mar 20203:12 pmRNSResolutions adopted by the AGM 2020
10th Mar 20205:30 pmRNSBBVA Statement to Shareholders 2020 AGM
12th Feb 20208:50 amRNS2020 AGM Proposed Resolutions
11th Feb 20207:00 amRNSFinal dividend calendar 2019
10th Feb 20205:33 pmRNS2020 AnnualGeneral Meeting Call
5th Feb 20204:26 pmRNSPost Stabilisation Notice - BBVA S.A.
31st Jan 20207:28 amRNS4Q19 Results Presentation
31st Jan 20207:25 amRNS4Q19 Results Press Release
31st Jan 20207:21 amRNS4Q19 Results Report
31st Jan 20207:14 amRNSFinal Dividend for 2019
21st Jan 20205:23 pmRNS4Q19 Results Presentation Announcement
7th Jan 20208:25 amRNSPre Stabilisation Notice - BBVA S.A
23rd Dec 20195:15 pmRNSEarly redemption of preferred securities
19th Dec 20195:48 pmRNSAdjustment Goodwill Group investment in the USA
5th Dec 201911:48 amRNSSREP Capital Requirements 2020
19th Nov 20196:30 pmRNSMREL Requirement
12th Nov 20198:50 amRNSPost-Stabilisation Notice - BBVA
31st Oct 20197:04 amRNS3Q19 Results Presentation
31st Oct 20197:00 amRNS3Q19 Results Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.